Clinical Trials Directory

Trials / Completed

CompletedNCT06051838

Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma

Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma: a Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
541 (actual)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Tumor deposits (TD), nodules in the peritumoral adipose tissue with no architectural residue of lymph node, which is a definition often being confusing to the extranodal extension (ENE), have been described in several malignancies and linked to a worse prognosis. In gastric cancer and colon cancer, TD and ENE should be distinguished and collected separately in 8th AJCC manual. However, in thyroid cancer, TD as a collection variable was absence in both the 8th AJCC manual and the 2015 ATA guideline. This is a study that revealed the presence of TD by reviewing a large number of papillary thyroid carcinoma (PTC) specimens and explored its prognostic value by constructing a nomogram to accurately predict disease-free survival in PTC patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgeryif the patients is TD positive, we recommond careful surgery and pathological examination.

Timeline

Start date
2022-11-01
Primary completion
2023-02-28
Completion
2023-03-30
First posted
2023-09-25
Last updated
2023-09-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06051838. Inclusion in this directory is not an endorsement.